159 related articles for article (PubMed ID: 12499921)
1. Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy.
Rickes S; Unkrodt K; Ocran K; Neye H; Wermke W
Pancreas; 2003 Jan; 26(1):76-81. PubMed ID: 12499921
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography.
Rickes S; Unkrodt K; Neye H; Ocran KW; Wermke W
Scand J Gastroenterol; 2002 Nov; 37(11):1313-20. PubMed ID: 12465731
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound.
Rickes S; Wermke W
J Gastroenterol Hepatol; 2004 Jul; 19(7):761-6. PubMed ID: 15209622
[TBL] [Abstract][Full Text] [Related]
4. Localisation of neuroendocrine tumours of the upper gastrointestinal tract.
Zimmer T; Ziegler K; Bäder M; Fett U; Hamm B; Riecken EO; Wiedenmann B
Gut; 1994 Apr; 35(4):471-5. PubMed ID: 8174983
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.
Scherübl H; Bäder M; Fett U; Hamm B; Schmidt-Gayk H; Koppenhagen K; Dop FJ; Riecken EO; Wiedenmann B
Gastroenterology; 1993 Dec; 105(6):1705-9. PubMed ID: 7902821
[TBL] [Abstract][Full Text] [Related]
6. Improved diagnosing of small hepatocellular carcinomas by echo-enhanced power Doppler sonography in patients with cirrhosis.
Rickes S; Schulze S; Neye H; Ocran KW; Wermke W
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):893-900. PubMed ID: 12867800
[TBL] [Abstract][Full Text] [Related]
7. [Pancreatic metastases of renal cell carcinomas - evaluation of the contrast behavior at echo-enhanced power-Doppler sonography in comparison to primary pancreatic tumors].
Rickes S; Flath B; Unkrodt K; Ocran K; Neye H; Lochs H; Wermke W
Z Gastroenterol; 2001 Aug; 39(8):571-8. PubMed ID: 11558060
[TBL] [Abstract][Full Text] [Related]
8. [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
Faiss S; Scherübl H; Bäder M; Fett U; Koppenhagen K; Wiedenmann B; Riecken EO
Z Gastroenterol; 1994 May; 32(5):243-6. PubMed ID: 7915450
[TBL] [Abstract][Full Text] [Related]
9. Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors.
Usmani S; Khan HA; Abdulla M; Ahmed N; abu Huda F; Marafi F; al Kandari F; al Mohannadi S; al Nafisi N
Med Princ Pract; 2011; 20(4):356-61. PubMed ID: 21576997
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study.
Napoleon B; Alvarez-Sanchez MV; Gincoul R; Pujol B; Lefort C; Lepilliez V; Labadie M; Souquet JC; Queneau PE; Scoazec JY; Chayvialle JA; Ponchon T
Endoscopy; 2010 Jul; 42(7):564-70. PubMed ID: 20593334
[TBL] [Abstract][Full Text] [Related]
11. Echo-enhanced sonography--an increasingly used procedure for the differentiation of pancreatic tumors.
Rickes S; Malfertheiner P
Dig Dis; 2004; 22(1):32-8. PubMed ID: 15292693
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of somatostatin receptor scintigraphy. Studies of pre- and intraoperative localization of gastrointestinal and pancreatic tumors].
Adams S; Baum RP; Adams M; Wenisch HJ; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
Med Klin (Munich); 1997 Mar; 92(3):138-43. PubMed ID: 9173204
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
14. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
Jamar F; Fiasse R; Leners N; Pauwels S
J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor scintigraphy in the diagnosis of neuroendocrine gastroenteropancreatic tumors.
Bäder M; Koppenhagen K
Recent Results Cancer Res; 1996; 142():137-62. PubMed ID: 8893340
[TBL] [Abstract][Full Text] [Related]
17. [Differential diagnosis of frequent pancreatic tumours with echo-enhanced power-Doppler sonography - presentation of case reports].
Rickes S; Unkrodt K; Neye H; Ocran K; Lochs H; Wermke W
Z Gastroenterol; 2002 Apr; 40(4):235-40. PubMed ID: 11961732
[TBL] [Abstract][Full Text] [Related]
18. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL
Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235
[TBL] [Abstract][Full Text] [Related]
19. [Somatostatin receptor scintigraphy (SRS) in a neuroendocrine pancreatic tumor: why SPECT?].
Lang O; Bihl H
Nuklearmedizin; 2000; 39(4):N55-7. PubMed ID: 10919167
[No Abstract] [Full Text] [Related]
20. Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Hasegawa S; Kobayashi N; Tokuhisa M; Goto A; Takano S; Takada Y; Kaneta T; Mori R; Matsuyama R; Endo I; Yamanaka S; Nakajima A; Inoue T; Ichikawa Y
Digestion; 2017; 96(1):13-20. PubMed ID: 28609761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
